AVR 0.89% $17.75 anteris technologies ltd

Vaxxas secures funding interest to see if professor Fraser utilizes nanopatch, page-77

  1. 6,439 Posts.
    lightbulb Created with Sketch. 42
    "Also what about the HPV Phase 1 trial and will require it require additional funds"
    Now yes it will as so far they have not said they have, although it will not be a big cost around 1 million.
    They are about to get back around 2 million in a rebate, some could go to upping the %age again, however the 1/2 yearly which is due Weds or Thursday maybe we may have paid for it in the last 2/4s maybe not. But I do think they may have but that is just a gut feeling only as there was an increase in spending which will be addressed in that 1/2 yearly it could have been done and we may not know until the release
    Last edited by >Russ<: 22/02/15
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$17.75
Change
-0.160(0.89%)
Mkt cap ! $341.1M
Open High Low Value Volume
$18.00 $18.10 $17.65 $53.47K 2.992K

Buyers (Bids)

No. Vol. Price($)
3 285 $17.65
 

Sellers (Offers)

Price($) Vol. No.
$17.75 2141 1
View Market Depth
Last trade - 15.58pm 16/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.